Antenatal iron and folic acid supplementation use by pregnant women in Khartoum, Sudan

Anaemia during pregnancy can lead to adverse maternal and perinatal outcomes. The WHO recommends that all pregnant women in areas where anaemia is prevalent receive supplements of iron and folic acid. However, due to many factors, the use of iron and folic acid supplementation is still low in many countries. This study was conducted to assess the rates of iron-folic supplementation and the associated factors during pregnancy and the effects of taking iron-folic acid supplementation on rates of maternal anaemia and low birth weight (LBW) infants. A cross-sectional study was conducted at Khartoum Hospital, Sudan. Enrolled women answered a questionnaire on socio-demographics characteristics, their pregnancy and delivery. Of 856 women, 788 (92.1%) used iron-folic acid supplementation during pregnancy and 65.4% used folic acid. While place of residence, occupation and level of education were not associated with iron-folic acid usage, older age (OR = 3, CI = 1.4-6.3) and use of antenatal care (OR = 14.3, CI = 7.4-27.5) were associated with iron-folic acid use. Primiparity (OR = 3.8, CI = 1.9-7.6), maternal employment (OR = 3.9, CI = 2.25-6.77) and use of antenatal care (OR = 7.9, CI = 4.1-15) were the factors associated with folic acid. Using iron-folic acid was protective against anaemia (OR = 0.39, CI = 0.2-0.7) and LBW infants (OR = 0.3, CI = 0.17-0.68). There was a high rate of iron-folic acid supplementation use among pregnant women in Khartoum, Sudan, which was beneficial in preventing anaemia in expectant mothers and infants of LBW.